Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Jiva Pharma synthesize new ascorbate esters of omega-3

Sep. 25, 2014

Allergan patents novel antibiotic conjugates for ocular disorders

Sep. 25, 2014

New agents for HCV infection disclosed by Idenix Pharmaceuticals

Sep. 25, 2014

Ajinomoto presents new MGAT2 inhibitors for obesity and dyslipidemia

Sep. 25, 2014

Researchers at Washington University disclose novel GABA(A) receptor modulators

Sep. 23, 2014

Novel BRD4 inhibitors synthesized by Bristol-Myers Squibb

Sep. 23, 2014

Purdue Pharma divulges novel Na(V)1.7 blockers for pain

Sep. 23, 2014

Novel ROCK1 and ROCK2 inhibitors disclosed by Bristol-Myers Squibb

Sep. 23, 2014

Therabiol divulges new vaccines for HIV infection

Sep. 22, 2014

Scientists at Bristol-Myers Squibb disclose new agents for cancer

Sep. 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...